{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:17:47Z","timestamp":1758806267888,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Akdeniz University Scientific Research Projects Coordination Unit","award":["TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793"],"award-info":[{"award-number":["TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793","TTU-2019-4793"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The role of genetic variants in Mucin-5B (MUC5B) and telomerase reverse transcriptase (TERT) in idiopathic pulmonary fibrosis (IPF) pathogenesis, as well as their associations with clinical characteristics, remain uncertain and may exhibit ethnic variations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This single-center, cross-sectional study aimed to investigate the distribution of MUC5B rs35705950 and TERT rs2736100 variants among Turkish IPF patients. Additionally, we assessed associations between these genetic variants and clinical parameters including gender-age-physiology (GAP) score, percent predicted forced vital capacity (FVC%), percent predicted diffusing capacity for carbon monoxide (DLCO%), and the presence of honeycombing on high-resolution computed tomography (HRCT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The allele frequency of the TERT rs2736100 variant showed no significant difference between IPF patients and healthy controls (41.7% vs. 43.7%, OR\u2009=\u20090.92, <jats:italic>p<\/jats:italic>\u2009=\u20090.73). Conversely, the allele frequency of the MUC5B rs35705950 variant was significantly higher in IPF patients compared to controls (39.6% vs. 12%, OR\u2009=\u20094.81, <jats:italic>p<\/jats:italic>\u2009=\u20090.0001). IPF patients carrying the homozygous MUC5B variant (TT) exhibited significantly higher mean FVC% values than those without the variant (GG) (82.2% vs. 71.7%, respectively; <jats:italic>p<\/jats:italic>\u2009=\u20090.004). Furthermore, the mean age at diagnosis was significantly older in IPF patients carrying at least one T allele of the MUC5B variant (GT\u2009+\u2009TT) compared to non-carriers (GG) (67.7 years vs. 62.3 years, respectively; <jats:italic>p<\/jats:italic>\u2009=\u20090.013).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings indicate that the MUC5B rs35705950 variant is significantly associated with increased IPF susceptibility among Turkish patients. In contrast, the TERT rs2736100 variant was not linked to IPF risk. Additionally, the presence of the MUC5B rs35705950 variant correlated with later disease onset and relatively preserved pulmonary function in this patient population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12890-025-03903-7","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:51:56Z","timestamp":1758804716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The distribution and the clinical importance of MUC5B and TERT variants in Turkish patients with idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Ay\u015fe","family":"\u00d6demi\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliye Candan","family":"\u00d6\u011f\u00fc\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asl\u0131","family":"Toylu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fclya","family":"Dirol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aykut","family":"\u00c7illi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"\u00d6zbudak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zden","family":"Alt\u0131ok Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fclay","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"3903_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0730-2","author":"G Sgalla","year":"2018","unstructured":"Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018. https:\/\/doi.org\/10.1186\/s12931-018-0730-2.","journal-title":"Respir Res"},{"issue":"16","key":"3903_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364(16):1503\u201312. https:\/\/doi.org\/10.1056\/NEJMoa1013660.","journal-title":"N Engl J Med"},{"issue":"8","key":"3903_CR3","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1371\/journal.pone.0070621","volume":"8","author":"R Borie","year":"2013","unstructured":"Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS One. 2013;8(8):e70621. https:\/\/doi.org\/10.1371\/journal.pone.0070621.","journal-title":"PLoS One"},{"issue":"4","key":"3903_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1164\/rccm.201509-1872LE","volume":"193","author":"Y Nakano","year":"2016","unstructured":"Nakano Y, Yang IV, Walts AD, Watson AM, Helling BA, Fletcher AA, et al. MUC5B promoter variant rs35705950 affects MUC5B expression in the distal airways in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2016;193(4):464\u20136. https:\/\/doi.org\/10.1164\/rccm.201509-1872LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"3903_CR5","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/jama.2013.5827","volume":"309","author":"AL Peljto","year":"2013","unstructured":"Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA. 2013;309(21):2232\u20139. https:\/\/doi.org\/10.1001\/jama.2013.5827.","journal-title":"JAMA"},{"issue":"1","key":"3903_CR6","doi-asserted-by":"publisher","first-page":"574A","DOI":"10.1097\/01.sa.0000435633.11233.8a","volume":"144","author":"GM Hunninghake","year":"2013","unstructured":"Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle J, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. Chest. 2013;144(1):574A. https:\/\/doi.org\/10.1097\/01.sa.0000435633.11233.8a.","journal-title":"Chest"},{"issue":"1","key":"3903_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12931-021-01694-z","volume":"22","author":"D Biondini","year":"2021","unstructured":"Biondini D, Cocconcelli E, Bernardinello N, Lorenzoni G, Rigobello C, Lococo S, et al. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment. Respir Res. 2021;22(1):98. https:\/\/doi.org\/10.1186\/s12931-021-01694-z.","journal-title":"Respir Res"},{"issue":"13","key":"3903_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa066157","volume":"356","author":"MY Armanios","year":"2007","unstructured":"Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007;356(13):1317\u201326. https:\/\/doi.org\/10.1056\/NEJMoa066157.","journal-title":"N Engl J Med"},{"issue":"10","key":"3903_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/jmg.2008.057356","volume":"45","author":"T Mushiroda","year":"2008","unstructured":"Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet. 2008;45(10):654\u20136. https:\/\/doi.org\/10.1136\/jmg.2008.057356.","journal-title":"J Med Genet"},{"issue":"6","key":"3903_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2609","volume":"45","author":"TE Fingerlin","year":"2013","unstructured":"Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013;45(6):613\u201320. https:\/\/doi.org\/10.1038\/ng.2609.","journal-title":"Nat Genet"},{"issue":"5","key":"3903_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trsl.2013.12.006","volume":"163","author":"R Wei","year":"2014","unstructured":"Wei R, Li C, Zhang M, Jones-Hall YL, Myers JL, Noth I, et al. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. Transl Res. 2014;163(5):494\u2013502. https:\/\/doi.org\/10.1016\/j.trsl.2013.12.006.","journal-title":"Transl Res"},{"issue":"3","key":"3903_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00537-2017","volume":"50","author":"RK Putman","year":"2017","unstructured":"Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson E, et al. The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes. Eur Respir J. 2017;50(3): 1700537. https:\/\/doi.org\/10.1183\/13993003.00537-2017.","journal-title":"Eur Respir J"},{"issue":"12","key":"3903_CR13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1164\/rccm.201903-0511OC","volume":"200","author":"BD Hobbs","year":"2019","unstructured":"Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, et al. Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(12):1402\u20136. https:\/\/doi.org\/10.1164\/rccm.201903-0511OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"3903_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fimmu.2016.00274","volume":"7","author":"A Kishore","year":"2016","unstructured":"Kishore A, \u017di\u017ekov\u00e1 V, Kocourkov\u00e1 L, Petrkova J, Bouros E, Nunes H, et al. Association study for 26 candidate loci in idiopathic pulmonary fibrosis patients from four European populations. Front Immunol. 2016;7:274. https:\/\/doi.org\/10.3389\/fimmu.2016.00274.","journal-title":"Front Immunol"},{"issue":"8","key":"3903_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S2213-2600(18)30135-8","volume":"6","author":"A Dressen","year":"2018","unstructured":"Dressen A, Abbas AR, Cabanski C, Reeder J, Ramalingam TR, Neighbors M, et al. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. Lancet Respir Med. 2018;6(8):603\u201314. https:\/\/doi.org\/10.1016\/S2213-2600(18)30135-8.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3903_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/resp.12466","volume":"20","author":"Y Horimasu","year":"2015","unstructured":"Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, et al. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology. 2015;20(3):439\u201344. https:\/\/doi.org\/10.1111\/resp.12466.","journal-title":"Respirology"},{"issue":"2","key":"3903_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1378\/chest.14-0867","volume":"147","author":"AL Peljto","year":"2015","unstructured":"Peljto AL, Selman M, Kim DS, Murphy E, Tucker L, Pardo A, et al. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries. Chest. 2015;147(2):460\u20134. https:\/\/doi.org\/10.1378\/chest.14-0867.","journal-title":"Chest"},{"issue":"1","key":"3903_CR18","doi-asserted-by":"publisher","first-page":"15307","DOI":"10.1038\/s41598-019-51902-6","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Zhuang Y, Peng H, Cao M, Li Y, Xu Q, et al. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort. Sci Rep. 2019;9(1):15307. https:\/\/doi.org\/10.1038\/s41598-019-51902-6.","journal-title":"Sci Rep"},{"issue":"5","key":"3903_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/br.2021.1463","volume":"15","author":"M Sterclova","year":"2021","unstructured":"Sterclova M, Kishore A, Sikorova K, Skibova J, Petrek M, Vasakova M. Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment. Biomed Rep. 2021;15(5):87. https:\/\/doi.org\/10.3892\/br.2021.1463.","journal-title":"Biomed Rep"},{"issue":"5","key":"3903_CR20","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3903_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","volume":"1","author":"I Noth","year":"2013","unstructured":"Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med. 2013;1(4):309\u201317. https:\/\/doi.org\/10.1016\/S2213-2600(13)70045-6.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"3903_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/thoraxjnl-2012-201786","volume":"68","author":"CJ Stock","year":"2013","unstructured":"Stock CJ, Sato H, Fonseca C, Banya WAS, Molyneaux PL, Adamali H, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax. 2013;68(5):436\u201341.","journal-title":"Thorax"},{"issue":"2","key":"3903_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.201810-1891OC","volume":"200","author":"C Moore","year":"2019","unstructured":"Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, et al. Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(2):199\u2013208.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3903_CR24","doi-asserted-by":"publisher","first-page":"24007","DOI":"10.1038\/s41598-021-03533-z","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li W, Luo Z, Chen Y. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis. Sci Rep. 2021;11(1):24007. https:\/\/doi.org\/10.1038\/s41598-021-03533-z.","journal-title":"Sci Rep"},{"issue":"6","key":"3903_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1183\/09031936.00163814","volume":"45","author":"JA Kropski","year":"2015","unstructured":"Kropski JA, Blackwell TS, Loyd JE. The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J. 2015;45(6):1717\u201327. https:\/\/doi.org\/10.1183\/09031936.00163814.","journal-title":"Eur Respir J"},{"issue":"3","key":"3903_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/thoraxjnl-2018-212430","volume":"74","author":"SK Mathai","year":"2019","unstructured":"Mathai SK, Humphries S, Kropski JA, Blackwell TS, Powers J, Walts AD, et al. MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis. Thorax. 2019;74(3):280\u20133. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212430.","journal-title":"Thorax"},{"issue":"4","key":"3903_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/resp.12728","volume":"21","author":"JJ Van der Vis","year":"2016","unstructured":"Van der Vis JJ, Snetselaar R, Kazemier KM, ten Klooster L, Grutters JC, van Moorsel CHM. Effect of MUC5B promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. Respirology. 2016;21(4):712\u20137. https:\/\/doi.org\/10.1111\/resp.12728.","journal-title":"Respirology"},{"key":"3903_CR28","doi-asserted-by":"publisher","unstructured":"Cosgrove GP, Groshong SD, Peljto AL, Talbert J, McKean D, Markin C et al. The MUC5B promoter polymorphism is associated with a less severe pathological form of familial interstitial pneumonia. Am J Respir Crit Care Med. 2012;185:A6865. https:\/\/doi.org\/10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A6865","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A6865"},{"issue":"4","key":"3903_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.201406-1162OC","volume":"191","author":"JA Kropski","year":"2015","unstructured":"Kropski JA, Pritchett JM, Zoz DF, Crossno PF, Markin C, Garnett ET, et al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am J Respir Crit Care Med. 2015;191(4):417\u201326. https:\/\/doi.org\/10.1164\/rccm.201406-1162OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3903_CR30","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.chest.2015.11.009","volume":"149","author":"JH Chung","year":"2016","unstructured":"Chung JH, Peljto AL, Chawla A, Talbert JL, McKean DF, Rho BH, et al. CT imaging phenotypes of pulmonary fibrosis in the MUC5B promoter site polymorphism. Chest. 2016;149(5):1215\u201322. https:\/\/doi.org\/10.1016\/j.chest.2015.11.009.","journal-title":"Chest"},{"issue":"8","key":"3903_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","volume":"5","author":"B Ley","year":"2017","unstructured":"Ley B, Newton CA, Arnould I, Elicker BM, Henry TS, Vittinghoff E, et al. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. Lancet Respir Med. 2017;5(8):639\u201347. https:\/\/doi.org\/10.1016\/S2213-2600(17)30216-3.","journal-title":"Lancet Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03903-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:51:57Z","timestamp":1758804717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03903-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3903"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03903-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Clinical Research Ethics Committee of Akdeniz University Faculty of Medicine on 21 November 2018 (Decision Number: 816). Written informed consent was obtained from all participants prior to their inclusion in the study. The study was conducted in full accordance with the ethical principles outlined in the Declaration of Helsinki. Financial support for the study was provided by the Akdeniz University Scientific Research Projects Coordination Unit (Project Number: TTU-2019-4793).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of Akdeniz University or any affiliated institutions.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"429"}}